Otto Kauko, M.D., Ph.D.
otkauko [at] utu.fi
University of Turku
P.O. Box 123
FIN-20521 Turku, Finland
We study the essential outcomes of cancer cell signaling by utilizing a range of proteomics, single-cell omics, and genome editing techniques. Current projects focus on the regulation of rRNA synthesis, proteogenomic analyses of head and neck cancers, targeted therapy resistance in melanoma, and acid-labile phosphorylation.
Our group operates in Turku Proteomics facility. More information about the people and the mass spec laboratory can be found here: Turku Proteomics Facility
Kauko et al. BioRxiv. BioRxiv
Pihlajamaa, Kauko et al. Nat Biotechnol 2022. PubMed
Kauko et al. J Biol Chem 2020. PubMed
Kauko et al. Sci Transl Med 2018. PubMed